The dimorphic fungus Candida albicans is one of the most important fungi in medicine (26) . It is a member of the normal flora residing in the intestinal tract of humans and other animals and is thought to be acquired during passage through the birth canal (26) . C. albicans is also the model system for studying the basic biology of dimorphic fungi. Because of its medical importance, molecular tools are available with C. albicans that are unavailable for other dimorphic fungi (3) . One unresolved problem in fungal biology is the dependence of cell morphology on initial cell density. For fungi exhibiting yeast-mycelium dimorphism, this phenomenon has been termed the inoculum size effect (19) . Under otherwise identical conditions, budding yeasts are produced following inoculation at Ն10 6 cells/ml, whereas germ tubes and mycelia are produced with inocula of Ͻ10 6 cells/ml. We believe the inoculum size effect is a general phenomenon for all dimorphic fungi. This effect has been especially well documented for C. albicans. Cell density is listed by Odds (26) as 1 of 11 general factors favoring the filamentous form.
In this study we isolate and characterize the extracellular quorum-sensing molecule (QSM) which is responsible for the inoculum size effect in C. albicans. Quorum sensing is a wellknown phenomenon in prokaryotes, but it has as yet only been hinted at in eukaryotes (18) . Furthermore, since quorum sensing uses extracellular signal molecules, it is poised to mediate interactions of the producing fungus with its chemical and physical environment as well as with other bacteria and fungi. This study is the first to identify an extracellular molecule (farnesol) which mediates a eukaryotic quorum-sensing system. stock and 0.4 ml of the GPP/GPR vitamin stock (19) were added aseptically. The final pH was ca. 5.6. The modified GSB was used for preparing C. albicans cell stocks. Cells were harvested after 30 h of growth, washed twice in 50 mM K 2 HPO 4 buffer (pH 6.5), and stored at 4°C in the same buffer at a cell density of ca. 2 ϫ 10 9 cells/ml. Supernatants containing QSM activity were prepared following 24 h of growth in GPP at 28°C, starting with an initial cell density of 10 7 cells/ml. For QSM preparation, GPP was always prepared with Kandiyohi distilled water (Kandiyohi Bottled Water Co., Willmar, Minn.). This precaution was taken because several types of distilled water, including the building distilled water for the Beadle Center at the University of Nebraska at Lincoln, permitted ample growth of C. albicans, but the resulting cell-free supernatants did not contain QSM activity. Currently, five of eight distilled waters locally available in Lincoln and central Minnesota permit QSM accumulation. For the experiments to determine the influence of carbon source on QSM production, the glucose in GPP was replaced successively by lactose, sucrose, galactose, fructose, starch, and glycerol. For the experiments to determine the influence of nitrogen source on QSM production, the proline in GPP was replaced successively by L-serine, L-arginine, L-alanine, L-histidine, L-threonine, L-methionine, and L-phenylalanine. The pH values for all of the resulting spent media were very similar (pH 6.1 to 6.4). The sample of mixed isomer farnesol was purchased from Acros Organics (Pittsburgh, Pa.) while (E,E)-farnesol and farnesyl pyrophosphate were purchased from Sigma (St. Louis, Mo.). (E,E)-Farnesol is also called trans-trans farnesol.
QSM bioassay. Two complementary bioassays were used, both assessing the percent germ tube formation (GTF) at 37°C but differing in whether or not the cells are provided with a complete growth medium during the bioassay. The first, an N-acetylglucosamine (GlcNAc)-triggered differentiation assay, included 0.56 ml of 0.1 M imidazole buffer (pH 6.5), 0.15 ml of 0.1 M MgSO 4 , 0.13 ml of 0.1 M GlcNAc, and 4.16 ml of either Kandiyohi distilled water or filter-sterilized supernatant.
Bioassays of commercial chemicals were conducted by the addition of the chemical, as a solution in 100% methanol, to the bioassay media; the final concentration of methanol was never greater than 1%. The second, a mycelial growth assay, included 0.5 ml of 0.5 M potassium phosphate buffer (pH 6.5), 0.5 ml of 20% glucose with 30 mM MgSO 4 , 0.17 ml of 0.3 M L-proline, 0.13 ml of 0.1 M GlcNAc, and 3.7 ml of either Kandiyohi distilled water or filter-sterilized supernatant. In both cases, the assays were conducted in 25-ml Erlenmeyer flasks using C. albicans inoculum which had been stored at 4°C in 50 mM potassium phosphate buffer (pH 6.5). The cells were added in ϳ25-l aliquots to prewarmed (37°C) assay medium to give a final cell density of 10 7 cells/ml. The flasks were shaken on a New Brunswick Scientific G2 shaker at 37°C and 225 rpm for 4 h and examined for percent GTF by phase-contrast microscopy. At time zero, the inoculated cells are Ͼ98% undifferentiated with 0% germ tubes and 0 to 2% budding yeasts.
Purification of QSM. Five liters GPP was inoculated to a final concentration of 10 7 cells/ml and incubated at 30°C for 24 h on a New Brunswick Scientific G52 shaker at 125 rpm. After 24 h the cultures were centrifuged at 15,300 ϫ g for 20 min. The supernatant was decanted and filter sterilized by vacuum filtration through Whatman (Maidstone, United Kingdom) 0.45-m (pore-size) cellulose nitrate filters. The cell-free supernatant was either designated as spent medium for use in a QSM assay or extracted with a one-fifth volume of ethyl acetate. The ethyl acetate was removed under reduced pressure on a rotary evaporator. The residue was suspended in a small volume of 1:4 ethyl acetate-hexane and the soluble portion was subjected to silica flash chromatography with 1:4 ethyl acetate-hexane as the eluant. Individual fractions (1 ml) were examined by thin-layer chromatography (TLC).
TLC. TLC was conducted on silica gel G plates (Al or glass backed) containing a fluorescent indicator (Alltech, Deerfield, Ill.). Reagents used for staining included 1% aqueous KMnO 4 , an indicator for alkenes, and a mixture of panisaldehyde and sulfuric acid in 1:1 methanol-water, which chars to reveal a variety of organic functional groups. The mobile phase used was 1:4 ethyl acetate-hexane.
HPLC. FARNESOL FROM C. ALBICANS
GC-MS.
Active fractions were resuspended in 100% methanol and analyzed by a Hewlett-Packard 5972 Series II gas chromatography-mass spectroscopy (GC-MS) with a 30-m DB-5 column in both the chemical ionization (methane) and electron ionization (EI) modes. GC used a 1.5-l sample, injector, and detector temperatures of 250 and 280°C, respectively, and a temperature program of 100°C for 3 min and then 20°C/min until 280°C. MS used a 3-min solvent delay and a scan rate of 1.5 scans/s.
Trimethylsilyl derivatization. Derivatization of the hydroxyl groups of commercial farnesol and QSM was accomplished by the addition of N,O-bis(trimethyl)trifluoroacetamide (BSTFA; Alltech). The samples were suspended in 500 l of ethyl acetate, from which 150 l was removed for analysis as "prior to derivatization." To the remaining 350 l, 100 l of BSTFA was added. The samples were heated for 15 min at 70°C in a water bath and, after cooling, were submitted directly for GC-MS.
RESULTS
QSM from C. albicans. Including spent media from C. albicans as part of the fresh growth media caused a gradual shift in the morphology of C. albicans. At 37°C, with no added culture supernatant, the cells were ca. 90% mycelia. Incorporation of spent growth medium progressively decreased the percent mycelia to only 5 to 10% (Fig. 1 ). This decrease in the percent mycelia occurred for both a complete growth medium and a GlcNAc-induced differentiation assay for GTF. In both cases, QSM did not just prevent GTF but also caused a morphological shift to actively budding yeast cells.
Both the growth assay and the differentiation assay ( Fig. 1 ) used cell densities of 10 7 cells/ml with cells that had been washed three times in 50 mM potassium phosphate buffer (pH 6.5). We washed the cells to remove residual QSM activity that had accumulated during their growth in GSB medium. Two washes were sufficient for maximum GTF during the assay even though the first four washes still contained measurable QSM activity (data not shown). For the cell growth bioassay ( Fig. 1) , varying the initial cell density from 5 ϫ 10 4 to 5 ϫ 10 7 /ml did not influence the results; QSM-containing spent media shifted the percent mycelia from ca. 80 to 11% (data not shown). For all subsequent assays we chose a cell density of 10 7 /ml so as to avoid the reduced GTF evident at cell densities of Ͼ5 ϫ 10 7 /ml, presumably due to QSM produced during the 4-h bioassay.
Generality within C. albicans. QSM activity was not specific for strain A72; it was general for all strains of C. albicans (Table 1) . Supernatant from strain A72 caused a myceliumto-yeast conversion in cells from strains MEN, SG5314, LGH1095, SG3314, and 10261 (Table 1) . Similarly, supernatants from strains MEN, SG5314, LGH1095, SG3314, and 10261 caused a mycelium-to-yeast conversion in A72 cells (Table 1). Thus, all six strains of C. albicans produce QSM activity, and the QSMs for the six strains are either identical or very similar to one another.
An exceptionally wide variety of conditions have been reported to favor filamentation in C. albicans (26) . Of these, the most widely used methods for inducing germ tubes are serum (15) , buffered GlcNAc (30, 31) , and L-proline (8) . However, QSM activity is not specific for a given method for germ tube induction ( Table 2 ). QSM acts to suppress germ tube induction by GlcNAc, by serum, by L-proline, or by GlcNAc and proline in combination ( Fig. 1 and Table 2 ).
Production of QSM by C. albicans. QSM was produced by C. albicans cells growing at all temperatures tested from 23 to 43°C (Table 3) . From 23 to 37°C, there was a rough correlation between cell number (in CFU/milliliters) and levels of QSM produced, as indicated by the lower percent mycelia when 
a Germ tube inducers present in 50 mM potassium phosphate (pH 6.5). b "Y" and "M" are as defined in Table 1 , footnote a. Supernatant was from A-72 cells grown in GPP at 30°C for 24 h at 125 rpm at an inoculum of 10 7 cells per ml. "Without used supernatant" samples received an equal amount of water or 50 mM potassium phosphate (pH 6.5) instead of supernatant.
c The serum was nonpregnant pig serum. 
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a Morphology for the indicated strain in the growth-based bioassay in Fig. 1 . For the control, no QSM or spent media were added. Y, percent budding yeasts; M, percent germ tubes for which the length of the germ tube was greater than the diameter of the cell. For all tables, the "Y" and "M" values were obtained as separate measurements so the values may not total 100%.
b Same experiment as in column 2 but with spent media from strain A-72. c Morphology of A72 incorporating spent media from the indicated strain of C. albicans.
those supernatants were tested in a germ tube bioassay (Table  3) . However, on a per-cell basis, significantly more QSM was produced by cells grown at 40°C than at any other temperature (Table 3) .
C. albicans cells synthesized QSM continuously during growth, and QSM activity persisted in the broth for at least 2 to 3 days after the onset of stationary phase (Fig. 2) . QSM production roughly paralleled cell growth (Fig. 2) , and the accumulation of QSM did not alter the growth rate of the producing culture until the normal onset of stationary phase.
The levels of QSM produced were not dependent on the type of growth medium or the specific carbon or nitrogen source provided. Equivalent per-cell QSM production was observed for cells grown (24 h at 25°C) in GPP, GSB (30) , modified GSB, Sabouraud-dextose, yeast extract-peptone-dextrose (1), yeast nitrogen base with either glucose or GlcNAc, or Lee's medium (20) (data not shown). Also, with GPP the identity of the carbon source and the nitrogen source did not seem to be important. Equivalent levels of QSM were produced with all seven carbon sources tested, including both fermentable and nonfermentable (glycerol) carbon sources, and all eight amino acid nitrogen sources (data not shown). The small variations in QSM detected correlated well with the cell titers obtained with the respective amino acids (data not shown).
Preliminary evidence on the chemical identity of QSM. For C. albicans, QSM activity could be extracted into ethyl acetate and then resuspended in either hexane or 90% methanol (6, 21) . Following an activity-directed purification, activity was associated with a fraction containing a molecular mass of 222 (6, 21). Cho et al. (6) eliminated the possibilities that QSM was methyl jasmonate or a lactone of jasmonic acid or homojasmonic acid. Active fractions of QSM are stained by dilute aqueous KMnO 4 on silica TLC, indicating the presence of carbon-carbon multiple bonds; absorb UV light at 210 to 220 nm but not at wavelengths of Ն240 nm; contain a free hydroxyl, as shown by altered mobility on TLC plates following trimethylsilylation; do not contain a free carboxylic acid, as shown by unaltered TLC mobility following reaction with diazomethane; and do not contain an ester linkage, as shown by the retention of activity after treatment with porcine liver esterase, hydrogen peroxide, basic methanol, or extremes in pH (e.g., pH 7 to 2 to 7 or pH 7 to 12 to 7). Additionally, C. albicans QSM is insensitive to trypsin, pronase, thermolysin, and proteinase K (100 g/ml for 2 h). Thus, QSM is unlikely to be a conventional peptide. This distinction is important because of recent evidence that the "asexual" C. albicans can, in   FIG. 2 . QSM production versus time. Supernatant samples were removed at the indicated times and used in the mycelial growth assay. Thus, a higher percent yeast indicates more QSM activity. Values are the average of triplicate experiments. Symbols: F, initial cell density of 10 7 /ml; s, initial cell density of 10 5 /ml. pH and CFU/milliliter values were also determined at each time point. The two cultures shifted from exponential to stationary phase at ca. 12 and 48 h, respectively, at a cell density of 2.8 ϫ 10 8 /ml in both cases. a Cultures were inoculated to a cell density of 10 7 per ml in GPP and incubated at the indicated temperature for 24 h on a New Brunswick Scientific G52 shaker at 125 rpm.
b Growth morphology-based bioassay was done as described in Fig. 1 (all at 37°C) using QSM from spent media produced by growth on GPP at the indicated temperatures. "Y" and "M" are as defined in Table 1 , footnote a.
fact, undergo mating (14, 23) . It is also unlikely to be an HSL. The C. albicans QSM was tested versus three bacterial strains which act as reporter strains for a wide range of bacterial HSLs (5, 29) . However, in no case did the C. albicans extracts elicit the indicated color development, while in each case the appropriate bacterial positive controls did elicit that response (data not shown).
Heat stability of QSM. The QSM activity of C. albicans was unchanged by heating at 100°C for 30 min or by autoclaving (data not shown), and activity was retained for at least 3 years at 4°C. It did not matter whether the supernatants were stored in glass or polypropylene vessels. Additionally, QSM activity remained unchanged following 12 freeze-thaw cycles (data not shown).
GC-MS.
Fractions enriched in the C. albicans QSM showed peaks at 9.8, 9.9, and 10.0 min when examined by GC-MS. These three peaks were analyzed with the MS system in both the chemical ionization (CI) mode (Fig. 3) , which emphasizes the parent compound's molecular weight, and the electron induced (EI) ionization mode (Fig. 4) , which emphasizes frag- mentation data. The three peaks contained the same parent ion (MϩH) at m/z 223 in CI mode (Fig. 3) and exhibited the same fragmentation patterns in EI mode (Fig. 4) . Presumably, the three peaks represent isomers of one another. Analysis of the results using a library search program (35) suggested 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol (molecular weight ϭ 222.37), better known as the 15-carbon sesquiterpene farnesol. Farnesol can exist as both E and Z geometric isomers at both the 2/3 and 6/7 double bonds, for a total of four possible isomers. When a commercial sample of farnesol, containing a mixture of isomers, was analyzed by GC-MS, three peaks were seen at 9.7, 9.85, and 10.0 min (data not shown) with the relative peak areas of 6:57:37. The commercial sample of (E,E)-farnesol showed only a single peak at 10.0 to 10.1 min (data not shown). In both the CI and the EI modes, the fragmentation patterns of QSM were identical to those of commercial farnesol. At no stage of the QSM analysis did we observe GC-MS peaks containing molecules of 154.2 or 290.5 molecular weight, as would be expected for geraniol (C 10 ) and geranylgeraniol (C 20 ), respectively. Farnesol bioassay data. Commercial preparations of mixedisomer farnesol (1-hydroxy-3,7,11-trimethyl-2,6,10-dodecatriene), (E,E)-farnesol, and mixed-isomer nerolidol (3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene) were tested for their ability to block GTF. All three showed strong QSM activity in that they reduced GTF by 50% at concentrations of 30 to 35 M for the farnesol preparations and of ca. 60 M for the nerolidol.
Two fractions (fractions 5 and 7) from a silica flash column separation of an ethyl acetate extract of the C. albicans supernate were compared by GC-MS. The three isomers of farnesol were separated by GC at 9.7, 9.85, and 10.0 min. For the comparatively inactive fraction 5 (87% GTF by bioassay), the three peaks were 65, 25, and 10% of the total peak area, respectively, whereas for the highly active fraction 7 (only 19% GTF by bioassay), the three peaks were 14, 6, and 80% of the total peak area, respectively.
Confirmation of farnesol by TLC. The R f values of commercial mixed isomer and (E,E)-farnesol were compared with those of the QSM-enriched fractions 5 and 7 from C. albicans supernatant. The mixed isomer farnesol ran as a broad band of R f 0.45 to 0.47, while the (E,E)-farnesol ran as a single band with R f 0.45, coeluting with the dominant band from the active fraction 7 from C. albicans. TLC analysis of the active chromatographic fractions derived from C. albicans also was conducted using p-anisaldehyde (data not shown). An advantage of this reagent is the ability to produce dramatically different colors depending upon the functionality present in the molecule (7). The two commercial farnesol bands stained blue green with p-anisaldehyde, as did the R f 0.45 and 0.47 bands from C. albicans supernatant. All of the other bands from C. albicans stained pink or yellow with p-anisaldehyde (data not shown). The apparent shift in QSM's R f value from 0.50 reported previously (6) to 0.45 merely reflects a switch in the TLC mobile phase from 25% ethyl acetate-hexane to 20% ethyl acetate-hexane. Confirmation of farnesol by HPLC. The commercial mixed isomer and (E,E)-farnesol were compared with the QSM-enriched fraction 7 from C. albicans by C 18 -reversed phase highpressure liquid chromatography (HPLC) monitored at 210 nm (Fig. 5) . The mixed-isomer farnesol showed peaks at 11.2, 11.7, and 12.4 min, which were present as the percent area in the ratio 6:56:38. In a separate experiment the (E,E)-farnesol showed a single peak at 12.4 min. This separation of the farnesol isomers duplicates the separation achieved by GC, and in both cases the (E,E)-isomer traveled the furthest. Once again, just as with the GC comparison, the position of the major peak for QSM enriched fraction 7 coincided with the peak for (E,E)-farnesol (Fig. 5) .
Farnesol and growth. In assessing the specificity of farnesol's QSM activity, it is important to determine whether farnesol slows down the overall growth rate for C. albicans. It did not. At concentrations of up to 250 M, farnesol did not alter the growth rate for C. albicans at 30°C. Actively budding yeasts were observed in both cases.
DISCUSSION
Our studies demonstrate that there is an inoculum size effect in the dimorphic fungus C. albicans that is mediated by extracellular farnesol. Farnesol acts as a QSM in that it prevents the mycelial phase of growth, with a mycelium/yeast threshold at ca. 10 6 cells/ml in liquid culture. Both QSM purified from C. albicans and commercial farnesol shifted the morphology of C. albicans from mycelia to actively budding yeasts and, at concentrations of up to 250 M, farnesol did not inhibit the growth rate of C. albicans. We hypothesize that the inoculum size effect is a common phenomenon in the biology of dimorphic fungi for which C. albicans is a useful model system.
We believe this report is the first structural identification of a quorum-sensing system in fungi and the first identification of farnesol production by C. albicans. Farnesol is not mentioned in Odds' (26) comprehensive review of Candida, two recent reviews of the lipids of C. albicans (16, 27) , or two standard texts on fungal physiology (10, 12) . Farnesol (QSM) is distinct from the morphogenic autoregulatory substance (MARS) isolated from C. albicans by Hazen and Cutler (13) . Both QSM and MARS are extracellular molecules produced by C. albicans that act to suppress the yeast-to-mycelium transition. However, MARS differs in that it has a UV maximum at 270 nm, has a nitrogen-containing ring system, reacts with ninhydrin to form a yellow color, has to be bioassayed within 2 days, is inactivated by pH values of Ͻ4.5 or Ͼ9.0, and has no aroma.
The physical properties of farnesol are appropriate for its role as a QSM; it is lipophilic, with a water solubility of only 1.2 mM (17) . In contrast, geranylgeraniol ( C 20 ) is not suitable as a QSM because it is not soluble in water, while geraniol (C 10 ) is sufficiently soluble (7.6 mM) but is generally toxic to strains of Candida (2) . The properties of farnesol as a QSM are consistent with those expected for a fungal quorum-sensing system. It is produced at all growth temperatures and is itself very heat stable. Even though QSM functions by inhibiting the shift from yeasts to mycelia, C. albicans produces as much or more QSM at temperatures of Ն37°C, where in vitro the cells are growing in the mycelial mode. This continued production of QSM at temperatures of Ն37°C. (i) explains why GTF assays at 37°C have to be conducted at cell densities of Յ10 7 /ml; (ii) means that QSM formation should occur in the human body during candidiasis; and (iii) precludes the simple, discontinuous model wherein GTF and mycelial growth only occur at temperatures of Ն37°C because QSM production does not occur at temperatures above 35 to 36°C.
Farnesol has three carbon-carbon double bonds and exists in four isomers. In this regard, we do not see any inconsistency between the facts that C. albicans excretes primarily the (E,E)-farnesol, while commercial (E,E)-farnesol and mixed-isomer farnesol have equivalent activities and the closely related sesquiterpene nerolidol is also highly active. The fungus Helminthosporium sativum has an enzymatic system for the cistrans isomerization of the 2,3 double bond of farnesol and epoxy-farnesol using nerolidol as an intermediate (32) . The presence of a similar system in C. albicans could allow interconversion of nerolidol and the two farnesols. Also, recognition that C. albican's QSM is slightly volatile explains. (i) why measurements of QSM's heat stability had to be conducted in sealed tubes; (ii) why there was a gradual decline in QSM activity during stationary phase (Fig. 2) , even though purified QSM was stable for at least 3 years at 4°C; and (iii) the difficulty we experienced in making quantitative comparisons between QSM activity in the initial supernatants and the amounts of farnesol purified following extraction into ethyl acetate-a high proportion of the farnesol was lost when the ethyl acetate was reduced in volume by rotary evaporation.
The older literature offers ample precedent for the existence of fungal QSMs. Odds (26) cited 13 references that an inoculum size of Յ10 6 /ml favored filamentous growth. A diffusible filament-suppressing molecule was hypothesized based on the distinctive morphology of C. albicans on agar plates following parallel streaking (24) or multiple cross-streaking (25) . For instance, Nickerson and Chung (25) noted the "suppression of filamentation in strain 582 (a wild-type dimorphic strain of C. albicans) along the length of the streak facing strain 806 and the appearance of filaments in 582 only at the free ends of lateral streaks," while with three parallel streaks filamentous cells only arose from the outer borders of the two outer streaks (24) . Similarly, Shepherd and Sullivan (30) noted that some C. albicans strains needed to be "activated or conditioned" for GTF by a prolonged aeration under nongrowing conditions. This conditioning, like the successive cell washings described here, would serve to remove excess QSM from the C. albicans cells.
Recognition that farnesol acts to suppress mycelial development in C. albicans in a quorum-sensing manner suggests that farnesol might be the first of a novel class of antifungal compounds. C. albicans normally occurs as a yeast in the human gastrointestinal tract but can form germ tubes in response to an unknown chemical inducer(s). The germ tubes (mycelia) can invade the intestinal wall to enter the blood stream. This morphological transformation from yeast to mycelia is a crucial step in the pathogenesis of C. albicans. Blocking this transition could block the pathogenic nature of this opportunist. These compounds would neither kill the fungi nor prevent their growth. Instead, they would limit their growth to a single morphological form and in so doing restrict pathogenesis. Nonfilamentous mutants of C. albicans are often avirulent (22) . We believe this type of single morphology therapy could be especially useful in immunocompromised patients because it would not upset the natural resident flora. Additionally, because it does not kill the fungus, selection for farnesol-tolerant mutants should not be as intense.
Finally, we suggest that the effects of excreted farnesol may be different in vitro and in vivo. All of our results so far have been in vitro; accumulated farnesol (10 to 50 M) shifted the morphology to budding yeasts. If this suppression of mycelial development also occurs in vivo, the effect of exogenous farnesol should be protective because nonfilamentous mutants of C. albicans are often avirulent (22) . However, in vivo farnesol excretion may instead act as a virulence factor. In patients, C. albicans accumulates to very high cell densities and then some of these cells penetrate the tissue. Growth to high cell densities in the restricted microenvironments of the host mucosal foci may produce enough farnesol so that the cells lining the microabscesses no longer constitute an effective barrier to fungal penetration. Free farnesol is not normally present at detectable levels in human plasma (28) . The lipophilic properties of free farnesol would favor its membrane localization, and thus VOL. 67, 2001 FARNESOL FROM C. ALBICANSit could alter the membrane fluidity of the host cells. Alternatively, according to Voziyan et al. (34) , the farnesol could reduce diacylglycerol production. Since diacylglycerol is an activator for protein kinase C, farnesol could inhibit cell growth, leading to apoptosis (34) , and thus create an entry site for invading C. albicans. Tests with farnesol and C. albicans in a mouse model system (9) should resolve these competing hypotheses.
